CLN8 gene therapy(Amicus Therapeutics)

N/A

Report date: 2023/05/22 10:18:07

Base Information

Drug NameCLN8 gene therapy(Amicus Therapeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsNeuronal Ceroid-Lipofuscinoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Ohio State UniversityNationwide Children'S Hospital
China Registration ClassN/A

Develop Information

Active CompaniesThe Ohio State UniversityNationwide Children'S Hospital
Inactive CompaniesN/A
Active IndicationsNeuronal Ceroid-Lipofuscinoses
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A